Ken Londoner is a researcher in the field of bioelectronic medicine. He is exploring the field’s applications across a variety of disease areas and disciplines, including neurology, auto-immune diseases, diabetes, arthritis, hypertension, pain management, cancer, and others.
Ken Londoner founded the privately held medical technology company BioSig Technologies in 2009. The company works on researching and developing a new system that would treat more accurately patients suffering from Atrial Fibrillation and Complex Arrhythmia.
Additionally, Londoner is also associated with Endicott Management Partners, another private investment company focused on medical technology and consumer-related companies, where he serves as Managing Partner. Prior to this, he served as Co-Founder and Member of Board of Directors at Safe Ports.
He studied at Lafayette College in Easton, Pennsylvania and holds a degree in economics and finance. He also earned his MBA from NYU’s Stern School of Business with a dual major in finance and management.
Similar users
